| Guidelines for the use and interpretation of assays for monitoring autophagy DJ Klionsky, FC Abdalla, H Abeliovich, RT Abraham, A Acevedo-Arozena, ... Autophagy 8 (4), 445-544, 2012 | 8139* | 2012 |
| Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors B Routy, E Le Chatelier, L Derosa, CPM Duong, MT Alou, R Daillère, ... Science 359 (6371), 91-97, 2018 | 853 | 2018 |
| Cancer stem cells SM Tu Origin of Cancers, 67-81, 2010 | 274 | 2010 |
| Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway—therapeutic perspectives in cancer Y Tao, V Pinzi, J Bourhis, E Deutsch Nature Reviews Clinical Oncology 4 (10), 591, 2007 | 248 | 2007 |
| Tumour stem cell-targeted treatment: elimination or differentiation C Massard, E Deutsch, JC Soria Annals of oncology 17 (11), 1620-1624, 2006 | 206 | 2006 |
| High-throughput genomics and clinical outcome in hard-to-treat advanced cancers: results of the MOSCATO 01 trial C Massard, S Michiels, C Ferté, MC Le Deley, L Lacroix, A Hollebecque, ... Cancer discovery 7 (6), 586-595, 2017 | 201 | 2017 |
| BCR-ABL down-regulates the DNA repair protein DNA-PKcs E Deutsch, A Dugray, B AbdulKarim, E Marangoni, L Maggiorella, ... Blood 97 (7), 2084-2090, 2001 | 192 | 2001 |
| Nanoscale radiotherapy with hafnium oxide nanoparticles L Maggiorella, G Barouch, C Devaux, A Pottier, E Deutsch, J Bourhis, ... Future oncology 8 (9), 1167-1181, 2012 | 177 | 2012 |
| Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: implication in radiation-induced vascular damages F Milliat, A François, M Isoir, E Deutsch, R Tamarat, G Tarlet, A Atfi, ... The American journal of pathology 169 (4), 1484-1495, 2006 | 141 | 2006 |
| Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers B Abdulkarim, S Sabri, E Deutsch, H Chagraoui, L Maggiorella, J Thierry, ... Oncogene 21 (15), 2334, 2002 | 141 | 2002 |
| Class I PI3 kinase inhibition by the pyridinylfuranopyrimidine inhibitor PI-103 enhances tumor radiosensitivity R Prevo, E Deutsch, O Sampson, J Diplexcito, K Cengel, J Harper, ... Cancer research 68 (14), 5915-5923, 2008 | 137 | 2008 |
| Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling A Ko, A Kanehisa, I Martins, L Senovilla, C Chargari, D Dugue, G Marino, ... Cell death and differentiation 21 (1), 92, 2014 | 124 | 2014 |
| A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma J Bourhis, R De Crevoisier, B Abdulkarim, E Deutsch, A Lusinchi, ... International Journal of Radiation Oncology* Biology* Physics 46 (5), 1105-1108, 2000 | 124 | 2000 |
| Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells B Wen, E Deutsch, E Marangoni, V Frascona, L Maggiorella, ... British journal of cancer 85 (12), 2017, 2001 | 120 | 2001 |
| The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy L Sancey, F Lux, S Kotb, S Roux, S Dufort, A Bianchi, Y Cremillieux, ... The British journal of radiology 87 (1041), 20140134, 2014 | 112 | 2014 |
| Down-regulation of BRCA1 in BCR-ABL–expressing hematopoietic cells E Deutsch, S Jarrousse, D Buet, A Dugray, ML Bonnet, ... Blood 101 (11), 4583-4588, 2003 | 110 | 2003 |
| Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology EJ Limkin, R Sun, L Dercle, EI Zacharaki, C Robert, S Reuzé, ... Annals of Oncology 28 (6), 1191-1206, 2017 | 109 | 2017 |
| Identifying the best machine learning algorithms for brain tumor segmentation, progression assessment, and overall survival prediction in the BRATS challenge S Bakas, M Reyes, A Jakab, S Bauer, M Rempfler, A Crimi, RT Shinohara, ... arXiv preprint arXiv:1811.02629, 2018 | 102 | 2018 |
| Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion A Kaliski, L Maggiorella, KA Cengel, D Mathe, V Rouffiac, P Opolon, ... Molecular cancer therapeutics 4 (11), 1717-1728, 2005 | 100 | 2005 |
| Drug insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy Y Loriot, G Perlemuter, D Malka, F Penault-Lorca, V Boige, E Deutsch, ... Nature Reviews Clinical Oncology 5 (5), 268, 2008 | 97 | 2008 |
Jean-Charles SoriaDrug Development Department, Gustave RoussyAdresse e-mail validée de gustaveroussy.fr
